News
InvestorsHub on MSN41m
Cognition Therapeutics Shares Jump 75% After FDA Discussion on Alzheimer’s TreatmentCognition Therapeutics Inc. (NASDAQ:CGTX) saw its stock climb sharply by 75% following a productive end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) concerning its Alzheimer’s ...
IFLScience on MSN43m
Alzheimer’s-Linked Protein Levels “20 Times Higher” In Newborn Babies – What Does This Mean?If you read any research about Alzheimer’s disease, two proteins are going to be your main characters. There’s amyloid-β, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback